PF-03893787
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PF-03893787, covering 2010-01-22 to 2010-03-18. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study To Evaluate The Safety And Tolerability Of Different Doses Of PF-03893787 In Healthy Adult Volunteers [Phase 1]